Carboplatin Treatment Options

A collection of 1673 research studies where Carboplatin is the interventional treatment. These studies are located in the United States. Carboplatin is used for conditions such as Non-Small Cell Lung Cancer, Ovarian Cancer and Lung Cancer.

Home

All Treatments

Carboplatin

Show Filters

Match to Clinical Trials

Access to cutting-edge treatments

Latest clinical trials

Find trials in your area

Start Matching

Filter by Age

Featured Trial

Paid Clinical Studies Nationwide

Recruiting

Nationwide clinical trials offered in your area. Some trials offering up to several thousand dollars in compensation for participation.

Conditions:

Healthy

Healthy Volunteer Study

Learn More

* Compensation for time may be available

Featured Offer

Lose Weight with GLP-1 Medications

Recruiting

Policy Lab has partnered with OnlineSemaglutide.org to offer trusted access to semaglutide and other GLP-1 medications, including generic alternatives to Ozempic® and Wegovy®.

GLP-1 medications are scientifically backed to help individuals achieve significant weight loss—on average, 15-20% of body weight within a year.

As a valued user, you’re eligible for $100 off your first program with code policy-lab-100.

Conditions:

Overweight

Overweight and Obesity

Obesity

Weight Loss

Morbid Obesity

Learn More

Stereotactic Body Radiation Therapy for Inoperable Locally-advanced Non-small Cell Lung Cancer

NCT01899989

Completed

The purpose of this study is to determine if the use of exploratory immunologic biomarkers, functional MRI images can serve as early predictors for response of NSCLC. It also will provide important information on the perceived side effects from a patient perspective. Patients may participate if they have tumors ≥3 cm without lymph node involvement (for which chemotherapy is not part of the standard of care). Patients will only receive stereotactic body radiation therapy (SBRT) per standard dose... Read More

Gender:

ALL

Ages:

18 years and above

Trial Updated:

10/02/2024

Locations: Memorial Sloan Kettering Cancer Center at Basking Ridge, Basking Ridge, New Jersey +7 locations

Conditions: Non-small Cell Lung Cancer

Learn More ›

Veliparib With Carboplatin and Paclitaxel and as Continuation Maintenance Therapy in Adults With Newly Diagnosed Stage III or IV, High-grade Serous, Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer

NCT02470585

Terminated

The primary objective of the study was to evaluate whether progression-free survival (PFS) was prolonged with the addition of veliparib to standard platinum-based chemotherapy (carboplatin/paclitaxel \[C/P\]) and continued as maintenance therapy compared with chemotherapy alone.

Gender:

FEMALE

Ages:

18 years and above

Trial Updated:

10/02/2024

Locations: University of Alabama at Birmingham - Main /ID# 138087, Birmingham, Alabama +209 locations

University of Alabama at Birmingham - Main /ID# 138087, Birmingham, Alabama

Tennessee Valley Gyn-Onc /ID# 139548, Huntsville, Alabama

University of South Alabama /ID# 138091, Mobile, Alabama

Alaska Womens Cancer Care /ID# 138231, Anchorage, Alaska

Arizona Oncology Associates, PC-HOPE /ID# 142002, Tucson, Arizona

Arizona Oncology Associates, PC-HOPE /ID# 143805, Tucson, Arizona

Arizona Oncology Associates, PC-HOPE /ID# 143806, Tucson, Arizona

Arizona Oncology Associates, PC-HOPE /ID# 143808, Tucson, Arizona

University of Arizona Cancer Center - North Campus /ID# 138084, Tucson, Arizona

University of Arizona Cancer Center - North Campus /ID# 139495, Tucson, Arizona

University of Arkansas for Medical Sciences /ID# 138253, Little Rock, Arkansas

John Muir Medical Center /ID# 139618, Concord, California

Ucsd /Id# 140323, La Jolla, California

Long Beach Memorial Medical Ct /ID# 147526, Long Beach, California

Kaiser Permanente /ID# 141305, Los Angeles, California

University of California, Los Angeles /ID# 138179, Los Angeles, California

Medical Oncology Care Assoc /ID# 139498, Orange, California

Univ CA, Irvine Med Ctr /ID# 139613, Orange, California

UC Davis Comprehensive Cancer Center - Main /ID# 144439, Sacramento, California

California Pacific Medical Ctr /ID# 138177, San Francisco, California

Kaiser Permanente - San Francisco /ID# 142051, San Francisco, California

Univ California, San Francisco /ID# 138178, San Francisco, California

Kaiser Permanente-Santa Clara /ID# 142053, Santa Clara, California

Stanford University School of Med /ID# 139450, Stanford, California

Palo Alto Medical Foundation /ID# 139452, Sunnyvale, California

Kaiser Permanente Medical Ctr-Vallejo /ID# 139492, Vallejo, California

Kaiser Permanente- Walnut Creek /ID# 142052, Walnut Creek, California

Kaiser Permanente, Waterpark III Institute for Health Research /ID# 139499, Aurora, Colorado

Univ of Colorado Cancer Center /ID# 138016, Aurora, Colorado

Hartford Healthcare /ID# 138184, New Britain, Connecticut

Yale University /ID# 138056, New Haven, Connecticut

University of Miami /ID# 139457, Miami, Florida

Women's Cancer Associates /ID# 140321, Saint Petersburg, Florida

Sarasota Memorial Health Care /ID# 138180, Sarasota, Florida

Moffitt Cancer Center /ID# 138061, Tampa, Florida

Georgia Regents University /ID# 138085, Augusta, Georgia

IACT Health /ID# 138058, Columbus, Georgia

Memorial Health Univ Med Ctr /ID# 138019, Savannah, Georgia

St. Joseph's/Candler /ID# 138090, Savannah, Georgia

The Queens Medical Center /ID# 141709, Honolulu, Hawaii

Kapiolani Medical Center /ID# 140319, Honolulu, Hawaii

Rush University Medical Center /ID# 143491, Chicago, Illinois

University of Chicago /ID# 139612, Chicago, Illinois

NorthShore University HealthSystem - Evanston Hospital /ID# 139451, Evanston, Illinois

Sharma, Hinsdale, IL /ID# 140326, Hinsdale, Illinois

Advocate Lutheran General Hosp /ID# 139489, Park Ridge, Illinois

Indiana Univ School Medicine /ID# 139610, Indianapolis, Indiana

Saint Vincent /ID# 139537, Indianapolis, Indiana

McFarland Clinic, PC /ID# 139455, Ames, Iowa

University of Iowa Hospitals and Clinics /ID# 138082, Iowa City, Iowa

Univ Kansas Med Ctr /ID# 140322, Kansas City, Kansas

Baptist Health Lexington /ID# 139542, Lexington, Kentucky

University of Kentucky Chandler Medical Center /ID# 138060, Lexington, Kentucky

Norton Cancer Institute /ID# 139567, Louisville, Kentucky

MMP Women's Health /ID# 139544, Portland, Maine

Greater Baltimore Medical Ctr /ID# 138049, Baltimore, Maryland

Sinai Hospital of Baltimore /ID# 141306, Baltimore, Maryland

Weinberg Cancer Inst Franklin /ID# 138235, Rossville, Maryland

Baystate Medical Center /ID# 139456, Springfield, Massachusetts

UMass Memorial Medical Center /ID# 139458, Worcester, Massachusetts

Wayne State University /ID# 139601, Detroit, Michigan

Henry Ford Health System /ID# 139536, Detroit, Michigan

William Beaumont Hospital /ID# 139550, Royal Oak, Michigan

Mayo Clinic - Rochester /ID# 139565, Rochester, Minnesota

Mmcorc /Id# 139534, Saint Louis Park, Minnesota

St. Dominic Hospital /ID# 138241, Jackson, Mississippi

Ellis Fischel Cancer Center /ID# 139571, Columbia, Missouri

Washington University-School of Medicine /ID# 138089, Saint Louis, Missouri

Cancer Research For the Ozarks /ID# 139538, Springfield, Missouri

Ferrell-Duncan Clinic /ID# 143484, Springfield, Missouri

Nebraska Methodist Hospital /ID# 139600, Omaha, Nebraska

Womens Cancer Center of Nevada /ID# 138092, Las Vegas, Nevada

Renown Regional Medical Center /ID# 138237, Reno, Nevada

Dartmouth-Hitchcock Medical Center /ID# 139502, Lebanon, New Hampshire

MD Anderson Cancer Ctr at Coop /ID# 139616, Camden, New Jersey

Hackensack Univ Med Ctr /ID# 143776, Hackensack, New Jersey

University of New Mexico /ID# 144220, Albuquerque, New Mexico

SW Gynecologic Oncology Assoc /ID# 147097, Albuquerque, New Mexico

Women's Cancer Care Associates /ID# 138234, Albany, New York

Montefiore Medical Center /ID# 139585, Bronx, New York

SUNY Downstate Medical Center /ID# 139533, Brooklyn, New York

Roswell Park Comprehensive Cancer Center /ID# 138052, Buffalo, New York

Northwell Health /ID# 139572, Lake Success, New York

Icahn School of Med Mt. Sinai /ID# 139617, New York, New York

Columbia University Medical Center /ID# 138252, New York, New York

Memorial Sloan Kettering Cancer Center /ID# 138017, New York, New York

Memorial Sloan Kettering Cancer Center /ID# 154464, New York, New York

SUNY Upstate Medical University - Downtown /ID# 139513, Syracuse, New York

Hope Womens Cancer Centers /ID# 139614, Asheville, North Carolina

Univ NC Chapel Hill /ID# 138547, Chapel Hill, North Carolina

Atrium Health Carolinas Medical Center /ID# 139568, Charlotte, North Carolina

Presbyterian Cancer Center /ID# 139590, Charlotte, North Carolina

Duke University Medical Center /ID# 138048, Durham, North Carolina

Wake Forest Baptist Medical Center /ID# 139588, Winston-Salem, North Carolina

University of Cincinnati /ID# 139619, Cincinnati, Ohio

Univ Hosp Cleveland /ID# 139615, Cleveland, Ohio

Fairview Hospital /ID# 144403, Cleveland, Ohio

Cleveland Clinic Main Campus /ID# 139501, Cleveland, Ohio

The Ohio State University - Columbus /ID# 138053, Columbus, Ohio

Columbus NCORP /ID# 139587, Columbus, Ohio

Womens Cancer Center /ID# 138062, Kettering, Ohio

Hillcrest Hospital /ID# 144404, Mayfield Heights, Ohio

Univ Oklahoma HSC /ID# 138020, Oklahoma City, Oklahoma

Oklahoma Cancer Specialists /ID# 138059, Tulsa, Oklahoma

Willamette Valley Cancer Institute /ID# 140318, Eugene, Oregon

Kaiser Permanente, NW /ID# 138249, Portland, Oregon

Abington Memorial Hospital /ID# 138086, Abington, Pennsylvania

University of Pennsylvania /ID# 140079, Philadelphia, Pennsylvania

Thomas Jefferson University /ID# 138239, Philadelphia, Pennsylvania

Fox Chase Cancer Center /ID# 149479, Philadelphia, Pennsylvania

University of Pittsburgh MC /ID# 138054, Pittsburgh, Pennsylvania

Reading Hospital /ID# 138057, Reading, Pennsylvania

Women and Infants Hospital /ID# 138083, Providence, Rhode Island

Medical University of South Carolina /ID# 138181, Charleston, South Carolina

Sanford Research/USD /ID# 139624, Sioux Falls, South Dakota

Chattanoogas Program in Womens /ID# 139545, Chattanooga, Tennessee

Texas Oncology - Austin Central /ID# 143817, Austin, Texas

Texas Oncology - South Austin /ID# 143818, Austin, Texas

Texas Oncology - Bedford /ID# 143814, Bedford, Texas

Texas Oncology - Medical City Dallas /ID# 143809, Dallas, Texas

Texas Oncology - Medical City Dallas /ID# 143812, Dallas, Texas

Texas Oncology - Forth Worth /ID# 143811, Fort Worth, Texas

Houston Methodist Hospital - Scurlock Tower /ID# 138232, Houston, Texas

Memorial Hermann Hospital /ID# 138238, Houston, Texas

Texas Oncology - The Woodlands /ID# 142003, The Woodlands, Texas

Texas Oncology - Tyler /ID# 143810, Tyler, Texas

University of Utah /ID# 138250, Salt Lake City, Utah

University of Vermont Medical Center /ID# 138251, Burlington, Vermont

University of Virginia /ID# 138088, Charlottesville, Virginia

Carilion Roanoke Memorial Hosp /ID# 139602, Roanoke, Virginia

Skagit Valley Medical Center /ID# 139586, Mount Vernon, Washington

MultiCare Regional Cancer Ctr /ID# 149872, Puyallup, Washington

Multicare Institute for Research and Innovation /ID# 143485, Tacoma, Washington

HSHS St. Vincent Hospital /ID# 139453, Green Bay, Wisconsin

Froedtert & the Medical College of Wisconsin /ID# 139449, Milwaukee, Wisconsin

Coffs Harbour Health Campus /ID# 145132, Coffs Harbour, New South Wales

Gosford Hospital /ID# 145299, Gosford, New South Wales

St George Hospital /ID# 145138, Kogarah, New South Wales

Newcastle Private Hospital /ID# 145834, Lambton Heights, New South Wales

The Prince of Wales Hospital /ID# 145134, Randwick, New South Wales

Northern Cancer Institute /ID# 145681, St Leonards, New South Wales

Calvary Mater Newcastle /ID# 145139, Waratah, New South Wales

Westmead Hospital /ID# 145137, Westmead, New South Wales

Southern Medical Day Care Ctr /ID# 145133, Wollongong, New South Wales

The Townsville Hospital /ID# 149163, Douglas, Queensland

Royal Brisbane and Women's Hospital /ID# 145135, Herston, Queensland

Icon Cancer Centre /ID# 148208, South Brisbane, Queensland

Mater Misericordiae Limited /ID# 145682, South Brisbane, Queensland

Royal Adelaide Hospital /ID# 150071, Adelaide, South Australia

Monash Health /ID# 145297, Clayton, Victoria

Cabrini Health /ID# 145142, Malvern, Victoria

Royal Womens Hospital /ID# 145136, Parkville, Victoria

Sir Charles Gairdner Hospital /ID# 145140, Nedlands, Western Australia

St. John of God Subiaco Hosp /ID# 147742, Subiaco, Western Australia

Hc Ufmg /Id# 137156, Belo Horizonte, Minas Gerais

Hospital Sao Lucas da PUCRS /ID# 137157, Porto Alegre, Rio Grande Do Sul

Hospital de Cancer de Barretos /ID# 137121, Barretos, Sao Paulo

Centro de Referencia da Saude da Mulher - Hospital Perola Byington /ID# 137120, São Paulo, Sao Paulo

Instituto Nacional de Câncer José de Alencar Gomes da Silva (INCA) /ID# 137155, Rio de Janeiro, Not set

Vejle Sygehus /ID# 137262, Vejle, Syddanmark

Regionshospitalet Herning /ID# 137260, Herning, Not set

Rambam Health Care Campus /ID# 137434, Haifa, Not set

The Lady Davis Carmel MC /ID# 137537, Haifa, Not set

Shaare Zedek Medical Center /ID# 137435, Jerusalem, Not set

Meir Medical Center /ID# 139397, Kfar Saba, Not set

Sheba Medical Center /ID# 137436, Ramat Gan, Not set

Kaplan Medical Center /ID# 137536, Rehovot, Not set

Aichi Cancer Center Hospital /ID# 148398, Nagoya-shi, Aichi

National Hospital Organization Kyushu Cancer Center /ID# 149133, Fukuoka-shi, Fukuoka

Kurume University Hospital /ID# 148697, Kurume-shi, Fukuoka

Iwate Medical University Hospital /ID# 147721, Shiwa-gun, Iwate

Kumamoto University Hospital /ID# 154169, Kumamoto-shi, Kumamoto

Mie University Hospital /ID# 149169, Tsu-shi, Mie

Tohoku University Hospital /ID# 149818, Sendai-shi, Miyagi

Niigata University Medical & Dental Hospital /ID# 149488, Niigata-shi, Niigata

Kindai University Hospital /ID# 154947, Osaka-sayama, Osaka

Shizuoka Cancer Center /ID# 147723, Sunto-gun, Shizuoka

The Cancer Institute Hosp JFCR /ID# 148436, Koto-ku, Tokyo

Keio University Hospital /ID# 148326, Shinjuku-ku, Tokyo

Yamagata University Hospital /ID# 153646, Yamagata-shi, Yamagata

Hyogo Cancer Center /ID# 148327, Akashi, Not set

Kansai Rosai Hospital /ID# 149237, Amagasaki, Not set

The Jikei Univ. Kashiwa Hosp. /ID# 149238, Kashiwa-shi, Not set

St. Marianna Univ Hospital /ID# 149327, Kawasaki, Not set

NHO Kure Medical Center and Ch /ID# 148569, Kure, Not set

Shikoku Cancer Center /ID# 148382, Matsuyama, Not set

Osaka International Cancer Institute /ID# 150778, Osaka, Not set

Hokkaido Cancer Center /ID# 148570, Sapporo, Not set

The Jikei University Hospital /ID# 148691, Tokyo, Not set

National Cancer Center /ID# 139404, Goyang, Gyeonggido

Korea University Anam Hospital /ID# 136908, 성북구, Gyeonggido

Gangnam Severance Hospital /ID# 136835, Seoul, Seoul Teugbyeolsi

Samsung Medical Center /ID# 136834, Seoul, Seoul Teugbyeolsi

Seoul National University Hospital /ID# 136909, Seoul, Not set

Asan Medical Center /ID# 136836, Seoul, Not set

Auckland City Hospital /ID# 145123, Auckland, Not set

Uniwersyteckie C. Kliniczne /ID# 138021, Gdańsk, Not set

Hospital Duran i Reynals /ID# 137298, L'Hospitalet de Llobregat, Barcelona

Hospital Univ Vall d'Hebron /ID# 137297, Barcelona, Not set

Hospital Clinic de Barcelona /ID# 137300, Barcelona, Not set

Hospital Clin Univ San Carlos /ID# 137402, Madrid, Not set

Hosp Univ 12 de Octubre /ID# 137299, Madrid, Not set

Hosp Univ Madrid Sanchinarro /ID# 137414, Madrid, Not set

Fundacion Inst Valenciano Onc /ID# 137403, Valencia, Not set

Norfolk and Norwich Univ Hosp /ID# 137969, Norwich, Norfolk

Beatson west of scotland cancer center /ID# 137965, Glasgow, Scotland

Ninewells Hospital /ID# 137967, Dundee, Not set

James Paget University Hosp /ID# 137970, Great Yarmouth, Not set

Imanova Limited, Hammersmith Hospital /ID# 137966, London, Not set

Oxford Univ Hosp NHS Trust /ID# 137973, Oxford, Not set

Conditions: Ovarian Cancer, Ovarian Neoplasm

Learn More ›

Study of Efficacy and Safety of Pembrolizumab Plus Platinum-based Doublet Chemotherapy With or Without Canakinumab in Previously Untreated Locally Advanced or Metastatic Non-squamous and Squamous NSCLC Subjects

NCT03631199

Active Not Recruiting

This was a Phase III study of pembrolizumab plus platinum-based doublet chemotherapy with or without canakinumab in previously untreated locally advanced or metastatic non-squamous and squamous NSCLC participants.

Gender:

ALL

Ages:

18 years and above

Trial Updated:

09/27/2024

Locations: Pacific Shores Medical Group ., Long Beach, California +151 locations

Pacific Shores Medical Group ., Long Beach, California

USC Kenneth Norris Comprehensive Cancer Center ., Los Angeles, California

Advent Health Cancer Institute, Orlando, Florida

Dana Farber Cancer Institute, Boston, Massachusetts

Novartis Investigative Site, Caba, Buenos Aires

Novartis Investigative Site, Buenos Aires, Not set

Novartis Investigative Site, Westmead, New South Wales

Novartis Investigative Site, Wooloongabba, Queensland

Novartis Investigative Site, Melbourne, Victoria

Novartis Investigative Site, Murdoch, Western Australia

Novartis Investigative Site, Linz, Oberoesterreich

Novartis Investigative Site, Salzburg, Not set

Novartis Investigative Site, Barretos, SP

Novartis Investigative Site, Sao Paulo, SP

Novartis Investigative Site, Edmonton, Alberta

Novartis Investigative Site, Brampton, Ontario

Novartis Investigative Site, Toronto, Ontario

Novartis Investigative Site, Temuco, Region De La Araucania

Novartis Investigative Site, Santiago, Not set

Novartis Investigative Site, Harbin, Heilongjiang

Novartis Investigative Site, Wuhan, Hubei

Novartis Investigative Site, Changsha, Hunan

Novartis Investigative Site, Changchun, Jilin

Novartis Investigative Site, XI An, Shanxi

Novartis Investigative Site, Hangzhou, Zhejiang

Novartis Investigative Site, Beijing, Not set

Novartis Investigative Site, Valledupar, Cesar

Novartis Investigative Site, Brno, Czech Republic

Novartis Investigative Site, Brno Bohunice, Not set

Novartis Investigative Site, Ostrava Vitkovice, Not set

Novartis Investigative Site, Praha, Not set

Novartis Investigative Site, Herning, Not set

Novartis Investigative Site, Oulu, Not set

Novartis Investigative Site, Marseille cedex 20, Bouches Du Rhone

Novartis Investigative Site, Lyon, Not set

Novartis Investigative Site, Montpellier, Not set

Novartis Investigative Site, Nantes Cedex 1, Not set

Novartis Investigative Site, Paris, Not set

Novartis Investigative Site, Berlin, Not set

Novartis Investigative Site, Dresden, Not set

Novartis Investigative Site, Essen, Not set

Novartis Investigative Site, Georgsmarienhuette, Not set

Novartis Investigative Site, Gerlingen, Not set

Novartis Investigative Site, Gottingen, Not set

Novartis Investigative Site, Halle (Saale), Not set

Novartis Investigative Site, Heidelberg, Not set

Novartis Investigative Site, Koeln, Not set

Novartis Investigative Site, Leipzig, Not set

Novartis Investigative Site, Muenchen, Not set

Novartis Investigative Site, Athens, GR

Novartis Investigative Site, Athens, Not set

Novartis Investigative Site, Kowloon, Not set

Novartis Investigative Site, Veszprem, Not set

Novartis Investigative Site, Reykjavik, Not set

Novartis Investigative Site, Hyderabad, Andhra Pradesh

Novartis Investigative Site, Gurgaon, Haryana

Novartis Investigative Site, Pune, Maharashtra

Novartis Investigative Site, Jaipur, Rajasthan

Novartis Investigative Site, Hyderabad, Telangana

Novartis Investigative Site, Kolkata, West Bengal

Novartis Investigative Site, Avellino, AV

Novartis Investigative Site, Genova, GE

Novartis Investigative Site, Milano, MI

Novartis Investigative Site, Rozzano, MI

Novartis Investigative Site, Modena, MO

Novartis Investigative Site, Padova, PD

Novartis Investigative Site, Perugia, PG

Novartis Investigative Site, Parma, PR

Novartis Investigative Site, Orbassano, TO

Novartis Investigative Site, Nagoya, Aichi

Novartis Investigative Site, Sapporo city, Hokkaido

Novartis Investigative Site, Himeji, Hyogo

Novartis Investigative Site, Yokohama-city, Kanagawa

Novartis Investigative Site, Sakai, Osaka

Novartis Investigative Site, Sunto Gun, Shizuoka

Novartis Investigative Site, Chuo ku, Tokyo

Novartis Investigative Site, Ube-city, Yamaguchi

Novartis Investigative Site, Osaka, Not set

Novartis Investigative Site, Gyeonggi do, Korea

Novartis Investigative Site, Seoul, Seocho Gu

Novartis Investigative Site, Seoul, Not set

Novartis Investigative Site, Ashrafieh, Not set

Novartis Investigative Site, Saida, Not set

Novartis Investigative Site, Kuantan, Pahang

Novartis Investigative Site, Kuching, Sarawak

Novartis Investigative Site, Kuala Lumpur, Wilayah Persekutuan

Novartis Investigative Site, Kuala Lumpur, Not set

Novartis Investigative Site, Groningen, Not set

Novartis Investigative Site, Drammen, Not set

Novartis Investigative Site, Taguig City, Metro Manila

Novartis Investigative Site, Makati City, Not set

Novartis Investigative Site, Quezon, Not set

Novartis Investigative Site, San Juan City, Not set

Novartis Investigative Site, Gliwice, Not set

Novartis Investigative Site, Poznan, Not set

Novartis Investigative Site, Tomaszw Mazowiecki, Not set

Novartis Investigative Site, Lisboa, Not set

Novartis Investigative Site, Porto, Not set

Novartis Investigative Site, Craiova, Dolj

Novartis Investigative Site, Cluj-Napoca, Not set

Novartis Investigative Site, Arkhangelsk, Not set

Novartis Investigative Site, Omsk, Not set

Novartis Investigative Site, Pushkin Saint Petersburg, Not set

Novartis Investigative Site, Saint Petersburg, Not set

Novartis Investigative Site, St Petersburg, Not set

Novartis Investigative Site, Singapore, Not set

Novartis Investigative Site, Bratislava, Slovak Republic

Novartis Investigative Site, Partizanske, Not set

Novartis Investigative Site, Granada, Andalucia

Novartis Investigative Site, Malaga, Andalucia

Novartis Investigative Site, Badalona, Catalunya

Novartis Investigative Site, Barcelona, Catalunya

Novartis Investigative Site, San Sebastian, Pais Vasco

Novartis Investigative Site, Las Palmas de Gran Canaria, Not set

Novartis Investigative Site, Madrid, Not set

Novartis Investigative Site, Valencia, Not set

Novartis Investigative Site, Zaragoza, Not set

Novartis Investigative Site, Stockholm, Not set

Novartis Investigative Site, Basel, Not set

Novartis Investigative Site, Kaohsiung, Not set

Novartis Investigative Site, Tainan, Not set

Novartis Investigative Site, Taipei, Not set

Novartis Investigative Site, Taoyuan, Not set

Novartis Investigative Site, Songkhla, Hat Yai

Novartis Investigative Site, Khon Kaen, THA

Novartis Investigative Site, Bangkok, Not set

Novartis Investigative Site, Ankara, Not set

Novartis Investigative Site, Edirne, Not set

Novartis Investigative Site, Istanbul, Not set

Novartis Investigative Site, High Heaton, Newcastle Upon Tyne

Novartis Investigative Site, London, Not set

Novartis Investigative Site, Manchester, Not set

Novartis Investigative Site, Plymouth, Not set

Novartis Investigative Site, Hanoi, Not set

Conditions: Non-small Cell Lung Cancer

Learn More ›

A Study of BMS-986406 as Monotherapy and Combination Therapies in Participants With Advanced Tumors

NCT05298592

Completed

The purpose of this study is to assess the safety and tolerability of BMS-986406 administered alone, in combination with nivolumab, or in combination with nivolumab and platinum-doublet chemotherapy (PDCT) in participants with advanced tumors.

Gender:

ALL

Ages:

18 years and above

Trial Updated:

09/25/2024

Locations: Local Institution - 0021, Birmingham, Alabama +28 locations

Local Institution - 0021, Birmingham, Alabama

University California San Diego Moores Cancer Center, La Jolla, California

The Angeles Clinic and Research Institute, A Cedars-Sinai Affiliate, Los Angeles, California

UCLA Health, Los Angeles, California

Local Institution - 0001, Hackensack, New Jersey

Carolina BioOncology Institute, PLLC, Huntersville, North Carolina

Sanford Cancer Center, Sioux Falls, South Dakota

Mary Crowley Cancer Research - Medical City Hospital, Dallas, Texas

Local Institution - 0006, Richmond, Virginia

Local Institution - 0029, Viedma, Rio Negro

Local Institution - 0023, Rosario, Santa Fe

Local Institution - 0028, Buenos Aires, Not set

Local Institution - 0032, Cordoba, Not set

Local Institution - 0018, Brussel (Jette), Brussel

Local Institution - 0015, Edegem, MA

Local Institution - 0012, Brussels, Not set

Local Institution - 0031, Kashiwa-shi, Chiba

Local Institution - 0026, Seongnam, Gyeonggi-do

Local Institution - 0024, Seoul, Not set

Local Institution - 0027, Seoul, Not set

Local Institution - 0025, Seoul, Not set

Local Institution - 0008, Malaga, Andaluca

Local Institution - 0030, Barcelona, Not set

Local Institution - 0017, Barcelona, Not set

Institut Catala dOncologia ICO - Hospital Duran i Reynals Location, Barcelona, Not set

Local Institution - 0014, Madrid, Not set

Local Institution - 0009, Madrid, Not set

Local Institution - 0016, Madrid, Not set

Local Institution - 0033, Pamplona, Not set

Conditions: Advanced Cancer

Learn More ›

QUILT-2.017: Phase 1b/2 Study of AMG 479 in Combination With Paclitaxel and Carboplatin for 1st Line Treatment of Advanced Squamous Non-Small Cell Lung Cancer

NCT00807612

Terminated

This is a global, multicenter, 2-part, open-label phase 1b and single-arm phase 2 study designed to evaluate the safety and efficacy of AMG 479 in combination with paclitaxel and carboplatin for the first-line treatment of advanced squamous non-small cell lung carcinoma.

Gender:

ALL

Ages:

18 years and above

Trial Updated:

09/19/2024

Locations: Research Site, Fayetteville, Arkansas +24 locations

Conditions: Advanced Squamous Non-Small Cell Lung Cancer

Learn More ›

First-Line Tarlatamab in Combination With Carboplatin, Etoposide, and PD-L1 Inhibitor in Subjects With Extensive Stage Small Cell Lung Cancer (ES-SCLC)

NCT05361395

Active Not Recruiting

This is a phase 1b study to assess the safety and tolerability of tarlatamab in combination with programmed death ligand (PD-L1) inhibition with and without chemotherapy.

Gender:

ALL

Ages:

18 years and above

Trial Updated:

09/17/2024

Locations: University of Southern California, Norris Comprehensive Cancer Center, Los Angeles, California +43 locations

University of Southern California, Norris Comprehensive Cancer Center, Los Angeles, California

Christiana Care Health Services, Newark, Delaware

Henry Ford Health System, Detroit, Michigan

Rutgers Cancer Institute of New Jersey, New Brunswick, New Jersey

New York University Grossman School of Medicine and New York University Langone Hospitals, New York, New York

The University of North Carolina at Chapel Hill, Chapel Hill, North Carolina

Avera Cancer Institute, Sioux Falls, South Dakota

Swedish Cancer Institute Medical Oncology, Seattle, Washington

West Virginia University Health Sciences Center, Morgantown, West Virginia

Chris OBrien Lifehouse, Camperdown, New South Wales

Universitair Ziekenhuis Antwerpen, Edegem, Not set

Algemeen Ziekenhuis Maria Middelares, Gent, Not set

Jessa Ziekenhuis - Campus Virga Jesse, Hasselt, Not set

AZ Delta Campus Rumbeke, Roeselare, Not set

Princess Margaret Cancer Centre, Toronto, Ontario

CHU de Quebec Hopital de l Enfant Jesus, Quebec, Not set

Rigshospitalet, Kobenhavn, Not set

Centre Leon Berard, Lyon cedex 8, Not set

Centre Hospitalier Universitaire de Nantes, Hôpital Nord Laënnec, Saint Herblain, Not set

Gustave Roussy, Villejuif, Not set

Universitaetsklinikum Dresden, Dresden, Not set

Universitaetsklinikum Essen, Essen, Not set

Universitaetsklinikum Freiburg, Freiburg, Not set

Rambam Medical Center, Haifa, Not set

Hadassah Ein-Kerem Medical Center, Jerusalem, Not set

Rabin Medical Center, Petah Tikva, Not set

Sheba Medical Center, Ramat Gan, Not set

Azienda Ospedaliera Universitaria Renato Dulbecco, Catanzaro, Not set

Fondazione IRCCS San Gerardo dei Tintori, Monza (MB), Not set

Istituto Nazionale Tumori Regina Elena, Rome, Not set

National Cancer Center Hospital East, Kashiwa-shi, Chiba

The Cancer Institute Hospital of Japanese Foundation for Cancer Research, Koto-ku, Tokyo

Seoul National University Hospital, Seoul, Not set

Asan Medical Center, Seoul, Not set

Samsung Medical Center, Seoul, Not set

Universitair Medisch Centrum Groningen, Groningen, Not set

Institut Catala d Oncologia Badalona Hospital Universitari Germans Trias i Pujol, Badalona, Cataluña

Hospital Universitari Vall d Hebron, Barcelona, Cataluña

Hospital Universitario 12 de Octubre, Madrid, Not set

Universitaetsspital Basel, Basel, Not set

Inselspital Bern, Bern, Not set

National Cheng Kung University Hospital, Tainan, Not set

National Taiwan University Hospital, Taipei, Not set

Taipei Veterans General Hospital, Taipei, Not set

Conditions: Extensive Stage Small Cell Lung Cancer

Learn More ›

Combination Chemotherapy Followed By Peripheral Stem Cell Transplant in Treating Young Patients With Newly Diagnosed Supratentorial Primitive Neuroectodermal Tumors or High-Risk Medulloblastoma

NCT00336024

Active Not Recruiting

This randomized phase III trial is studying two different combination chemotherapy regimens to compare how well they work in treating young patients with newly diagnosed supratentorial primitive neuroectodermal tumors or high-risk medulloblastoma when given before additional intense chemotherapy followed by peripheral blood stem cell rescue. It is not yet known which combination chemotherapy regimen is more effective when given before a peripheral stem cell transplant in treating supratentorial... Read More

Gender:

ALL

Ages:

2 years and below

Trial Updated:

09/16/2024

Locations: Children's Hospital of Alabama, Birmingham, Alabama +144 locations

Children's Hospital of Alabama, Birmingham, Alabama

University of Alabama at Birmingham Cancer Center, Birmingham, Alabama

Phoenix Childrens Hospital, Phoenix, Arizona

Arkansas Children's Hospital, Little Rock, Arkansas

University of Arkansas for Medical Sciences, Little Rock, Arkansas

Kaiser Permanente Downey Medical Center, Downey, California

Loma Linda University Medical Center, Loma Linda, California

Miller Children's and Women's Hospital Long Beach, Long Beach, California

Children's Hospital Los Angeles, Los Angeles, California

Cedars Sinai Medical Center, Los Angeles, California

Valley Children's Hospital, Madera, California

Children's Hospital of Orange County, Orange, California

Sutter Medical Center Sacramento, Sacramento, California

University of California Davis Comprehensive Cancer Center, Sacramento, California

Rady Children's Hospital - San Diego, San Diego, California

UCSF Medical Center-Parnassus, San Francisco, California

Children's Hospital Colorado, Aurora, Colorado

Connecticut Children's Medical Center, Hartford, Connecticut

Alfred I duPont Hospital for Children, Wilmington, Delaware

Children's National Medical Center, Washington, District of Columbia

Broward Health Medical Center, Fort Lauderdale, Florida

Lee Memorial Health System, Fort Myers, Florida

Golisano Children's Hospital of Southwest Florida, Fort Myers, Florida

University of Florida Health Science Center - Gainesville, Gainesville, Florida

Memorial Regional Hospital/Joe DiMaggio Children's Hospital, Hollywood, Florida

Nemours Children's Clinic-Jacksonville, Jacksonville, Florida

University of Miami Miller School of Medicine-Sylvester Cancer Center, Miami, Florida

Nicklaus Children's Hospital, Miami, Florida

AdventHealth Orlando, Orlando, Florida

Arnold Palmer Hospital for Children, Orlando, Florida

Nemours Children's Clinic - Orlando, Orlando, Florida

Orlando Health Cancer Institute, Orlando, Florida

Nemours Children's Hospital, Orlando, Florida

Nemours Children's Clinic - Pensacola, Pensacola, Florida

Johns Hopkins All Children's Hospital, Saint Petersburg, Florida

Saint Joseph's Hospital/Children's Hospital-Tampa, Tampa, Florida

Saint Mary's Hospital, West Palm Beach, Florida

Children's Healthcare of Atlanta - Egleston, Atlanta, Georgia

Memorial Health University Medical Center, Savannah, Georgia

University of Hawaii Cancer Center, Honolulu, Hawaii

Saint Luke's Cancer Institute - Boise, Boise, Idaho

Lurie Children's Hospital-Chicago, Chicago, Illinois

Loyola University Medical Center, Maywood, Illinois

Advocate Children's Hospital-Oak Lawn, Oak Lawn, Illinois

Ascension Saint Vincent Indianapolis Hospital, Indianapolis, Indiana

University of Iowa/Holden Comprehensive Cancer Center, Iowa City, Iowa

University of Kentucky/Markey Cancer Center, Lexington, Kentucky

Norton Children's Hospital, Louisville, Kentucky

Tulane University School of Medicine, New Orleans, Louisiana

Eastern Maine Medical Center, Bangor, Maine

Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore, Maryland

Walter Reed National Military Medical Center, Bethesda, Maryland

Tufts Children's Hospital, Boston, Massachusetts

Dana-Farber Cancer Institute, Boston, Massachusetts

C S Mott Children's Hospital, Ann Arbor, Michigan

Michigan State University Clinical Center, East Lansing, Michigan

Corewell Health Grand Rapids Hospitals - Helen DeVos Children's Hospital, Grand Rapids, Michigan

Bronson Methodist Hospital, Kalamazoo, Michigan

Kalamazoo Center for Medical Studies, Kalamazoo, Michigan

Children's Hospitals and Clinics of Minnesota - Minneapolis, Minneapolis, Minnesota

University of Minnesota/Masonic Cancer Center, Minneapolis, Minnesota

Mayo Clinic in Rochester, Rochester, Minnesota

University of Mississippi Medical Center, Jackson, Mississippi

Children's Mercy Hospitals and Clinics, Kansas City, Missouri

Cardinal Glennon Children's Medical Center, Saint Louis, Missouri

Washington University School of Medicine, Saint Louis, Missouri

Mercy Hospital Saint Louis, Saint Louis, Missouri

Alliance for Childhood Diseases/Cure 4 the Kids Foundation, Las Vegas, Nevada

Nevada Cancer Research Foundation NCORP, Las Vegas, Nevada

Hackensack University Medical Center, Hackensack, New Jersey

Morristown Medical Center, Morristown, New Jersey

Rutgers Cancer Institute of New Jersey-Robert Wood Johnson University Hospital, New Brunswick, New Jersey

Newark Beth Israel Medical Center, Newark, New Jersey

Saint Joseph's Regional Medical Center, Paterson, New Jersey

Overlook Hospital, Summit, New Jersey

University of New Mexico Cancer Center, Albuquerque, New Mexico

Montefiore Medical Center - Moses Campus, Bronx, New York

Roswell Park Cancer Institute, Buffalo, New York

NYU Langone Hospital - Long Island, Mineola, New York

Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York, New York

NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York, New York

Memorial Sloan Kettering Cancer Center, New York, New York

University of Rochester, Rochester, New York

Stony Brook University Medical Center, Stony Brook, New York

New York Medical College, Valhalla, New York

UNC Lineberger Comprehensive Cancer Center, Chapel Hill, North Carolina

Carolinas Medical Center/Levine Cancer Institute, Charlotte, North Carolina

Novant Health Presbyterian Medical Center, Charlotte, North Carolina

Sanford Broadway Medical Center, Fargo, North Dakota

Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio

Rainbow Babies and Childrens Hospital, Cleveland, Ohio

Cleveland Clinic Foundation, Cleveland, Ohio

Nationwide Children's Hospital, Columbus, Ohio

Dayton Children's Hospital, Dayton, Ohio

ProMedica Toledo Hospital/Russell J Ebeid Children's Hospital, Toledo, Ohio

Mercy Children's Hospital, Toledo, Ohio

University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma

Legacy Emanuel Children's Hospital, Portland, Oregon

Legacy Emanuel Hospital and Health Center, Portland, Oregon

Oregon Health and Science University, Portland, Oregon

Geisinger Medical Center, Danville, Pennsylvania

Children's Hospital of Philadelphia, Philadelphia, Pennsylvania

Saint Christopher's Hospital for Children, Philadelphia, Pennsylvania

Children's Hospital of Pittsburgh of UPMC, Pittsburgh, Pennsylvania

Medical University of South Carolina, Charleston, South Carolina

Prisma Health Richland Hospital, Columbia, South Carolina

BI-LO Charities Children's Cancer Center, Greenville, South Carolina

Greenville Cancer Treatment Center, Greenville, South Carolina

Sanford USD Medical Center - Sioux Falls, Sioux Falls, South Dakota

East Tennessee Childrens Hospital, Knoxville, Tennessee

Vanderbilt University/Ingram Cancer Center, Nashville, Tennessee

Texas Tech University Health Sciences Center-Amarillo, Amarillo, Texas

Driscoll Children's Hospital, Corpus Christi, Texas

Medical City Dallas Hospital, Dallas, Texas

Cook Children's Medical Center, Fort Worth, Texas

Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center, Houston, Texas

Covenant Children's Hospital, Lubbock, Texas

Methodist Children's Hospital of South Texas, San Antonio, Texas

University of Texas Health Science Center at San Antonio, San Antonio, Texas

Primary Children's Hospital, Salt Lake City, Utah

University of Vermont and State Agricultural College, Burlington, Vermont

Inova Fairfax Hospital, Falls Church, Virginia

Naval Medical Center - Portsmouth, Portsmouth, Virginia

Virginia Commonwealth University/Massey Cancer Center, Richmond, Virginia

Seattle Children's Hospital, Seattle, Washington

Providence Sacred Heart Medical Center and Children's Hospital, Spokane, Washington

Mary Bridge Children's Hospital and Health Center, Tacoma, Washington

Marshfield Medical Center-Marshfield, Marshfield, Wisconsin

Children's Hospital of Wisconsin, Milwaukee, Wisconsin

Sydney Children's Hospital, Randwick, New South Wales

The Children's Hospital at Westmead, Westmead, New South Wales

Royal Children's Hospital, Parkville, Victoria

Princess Margaret Hospital for Children, Perth, Western Australia

Alberta Children's Hospital, Calgary, Alberta

British Columbia Children's Hospital, Vancouver, British Columbia

CancerCare Manitoba, Winnipeg, Manitoba

IWK Health Centre, Halifax, Nova Scotia

McMaster Children's Hospital at Hamilton Health Sciences, Hamilton, Ontario

Kingston Health Sciences Centre, Kingston, Ontario

Children's Hospital of Eastern Ontario, Ottawa, Ontario

Hospital for Sick Children, Toronto, Ontario

The Montreal Children's Hospital of the MUHC, Montreal, Quebec

Centre Hospitalier Universitaire Sainte-Justine, Montreal, Quebec

CHU de Quebec-Centre Hospitalier de l'Universite Laval (CHUL), Quebec, Not set

San Jorge Children's Hospital, San Juan, Not set

Conditions: Untreated Childhood Supratentorial Primitive Neuroectodermal Tumor, Anaplastic Medulloblastoma, Medulloblastoma, Supratentorial Embryonal Tumor, Not Otherwise Specified

Learn More ›

First-in-Human Study of EOS100850 (Inupadenant) in Patients with Cancer

NCT03873883

Completed

Multicenter, open-label, dose-escalation Phase I/Ib clinical study to evaluate the safety and tolerability, the MTD/RP2D, pharmacokinetics (PK), pharmacodynamics (PD), and antitumor activity of EOS100850 (Inupadenant) as a Single Agent and in Combination with Pembrolizumab and/or Chemotherapy in Participants with Advanced Cancers.

Gender:

ALL

Ages:

18 years and above

Trial Updated:

09/13/2024

Locations: Karmanos Cancer Institute, Michigan Center, Michigan +18 locations

Conditions: Solid Tumor, Adult

Learn More ›

Carboplatin or Olaparib for BRcA Deficient Prostate Cancer

NCT04038502

Recruiting

This is an unblinded, randomized clinical study comparing the efficacy of DNA damaging chemotherapy using carboplatin, to standard of care therapy for patients who have metastatic castrate resistant prostate cancer. This trial will use olaparib or carboplatin as initial therapy with crossover to the alternate or second-line drug after first progression for patients with tumors containing BARD1, BRCA1, BRCA2, BRIP1, CHEK1, FANCL, PALB2, RAD51B, RAD51C, RAD51D, or RAD54L inactivating mutations. P... Read More

Gender:

MALE

Ages:

18 years and above

Trial Updated:

09/13/2024

Locations: VA Greater Los Angeles Healthcare System, West Los Angeles, CA, West Los Angeles, California +17 locations

Conditions: Metastatic Castrate Resistant Prostate Cancer, BARD1, BRCA1, BRCA2, BRIP1, CHEK1, FANCL, PALB2, RAD51B, RAD51C, RAD51D, or RAD54L Mutations

Learn More ›

A Prospective Study of Daily Adaptive Radiotherapy to Better Organ-at-Risk Doses in Head and Neck Cancer

NCT04883281

Completed

Varian Medical Systems has recently deployed a completely novel radiation treatment system called EthosTM, a first-of-its-kind system that allows for daily adapative radiotherapy (DART), such that the treatment for that day can be created on-the-fly based on the patient's current positioning and anatomy. This system is commercially-available and FDA-approved, and UTSW Radiation Oncology has installed two such units. The ability to adjust the dose delivery every day means both that adaptive thera... Read More

Gender:

ALL

Ages:

18 years and above

Trial Updated:

09/11/2024

Locations: University of Texas Southwestern Medical Center, Dallas, Texas

Conditions: Head and Neck Cancer

Learn More ›

TheraT® Vectors (Vaccines) Combined With Chemotherapy to Treat HPV16 Head and Neck Cancers

NCT05108870

Recruiting

Doctors leading this study hope to learn about the safety and effectiveness of combining medications HB-201 and HB-202 (also known as TheraT® vectors) with chemotherapy using carboplatin and paclitaxel in the beginning of the study (induction) and if combining these medications can increase tumor shrinkage after therapy and reduce the amount of radiotherapy and chemotherapy that will later be needed. In addition, the study is looking at ways to reduce side effects overall using robotic surgery,... Read More

Gender:

ALL

Ages:

18 years and above

Trial Updated:

09/10/2024

Locations: University of Chicago, Chicago, Illinois

Conditions: Human Papilloma Virus, HPV, HPV Positive Oropharyngeal Squamous Cell Carcinoma, Head and Neck Cancer

Learn More ›

Nab-paclitaxel and Carboplatin Followed by Response-Based Local Therapy in Treating Patients With Stage III or IV HPV-Related Oropharyngeal Cancer

NCT02258659

Completed

This phase II trial studies nab-paclitaxel (paclitaxel albumin-stabilized nanoparticle formulation) and carboplatin followed by response-based local therapy in treating patients with stage III or IV human papillomavirus (HPV)-related oropharyngeal cancer. Drugs used in chemotherapy, such as paclitaxel albumin-stabilized nanoparticle formulation, carboplatin, hydroxyurea, fluorouracil, paclitaxel, and cisplatin, work in different ways to stop the growth of tumor cells, either by killing the cells... Read More

Gender:

ALL

Ages:

18 years and above

Trial Updated:

09/09/2024

Locations: University of Chicago, Chicago, Illinois

Conditions: Human Papilloma Virus Infection, Stage III Squamous Cell Carcinoma of the Oropharynx, Stage IVA Squamous Cell Carcinoma of the Oropharynx, Stage IVB Squamous Cell Carcinoma of the Oropharynx

Learn More ›

Browse by State

Carboplatin treatment options in Alabama

Carboplatin treatment options in Alaska

Carboplatin treatment options in Arizona

Carboplatin treatment options in Arkansas

Carboplatin treatment options in California

Carboplatin treatment options in Colorado

Carboplatin treatment options in Connecticut

Carboplatin treatment options in Delaware

Carboplatin treatment options in District of Columbia

Carboplatin treatment options in Florida

Carboplatin treatment options in Georgia

Carboplatin treatment options in Hawaii

Carboplatin treatment options in Idaho

Carboplatin treatment options in Illinois

Carboplatin treatment options in Indiana

Carboplatin treatment options in Iowa

Carboplatin treatment options in Kansas

Carboplatin treatment options in Kentucky

Carboplatin treatment options in Louisiana

Carboplatin treatment options in Maine

Carboplatin treatment options in Montana

Carboplatin treatment options in Nebraska

Carboplatin treatment options in Nevada

Carboplatin treatment options in New Hampshire

Carboplatin treatment options in New Jersey

Carboplatin treatment options in New Mexico

Carboplatin treatment options in New York

Carboplatin treatment options in North Carolina

Carboplatin treatment options in North Dakota

Carboplatin treatment options in Ohio

Carboplatin treatment options in Oklahoma

Carboplatin treatment options in Oregon

Carboplatin treatment options in Maryland

Carboplatin treatment options in Massachusetts

Carboplatin treatment options in Michigan

Carboplatin treatment options in Minnesota

Carboplatin treatment options in Mississippi

Carboplatin treatment options in Missouri

Carboplatin treatment options in Pennsylvania

Carboplatin treatment options in Rhode Island

Carboplatin treatment options in South Carolina

Carboplatin treatment options in South Dakota

Carboplatin treatment options in Tennessee

Carboplatin treatment options in Texas

Carboplatin treatment options in Utah

Carboplatin treatment options in Vermont

Carboplatin treatment options in Virginia

Carboplatin treatment options in Washington

Carboplatin treatment options in West Virginia

Carboplatin treatment options in Wisconsin

Carboplatin treatment options in Wyoming